Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phibro Animal Health (PAHC) Gains from Sales and Divestitures (2025)

Historic Gains from Sales and Divestitures for Phibro Animal Health (PAHC) over the last 1 years, with Q2 2025 value amounting to $30000.0.

  • Phibro Animal Health's Gains from Sales and Divestitures changed N/A to $30000.0 in Q2 2025 from the same period last year, while for Jun 2025 it was $30000.0, marking a year-over-year change of. This contributed to the annual value of $30000.0 for FY2025, which is N/A changed from last year.
  • Per Phibro Animal Health's latest filing, its Gains from Sales and Divestitures stood at $30000.0 for Q2 2025.
  • Over the past 5 years, Phibro Animal Health's Gains from Sales and Divestitures peaked at $30000.0 during Q1 2025, and registered a low of $30000.0 during Q1 2025.